Adial Pharmaceuticals, Inc. (ADIL)
NASDAQ: ADIL · Real-Time Price · USD
2.780
-0.020 (-0.71%)
At close: Jul 10, 2026, 4:00 PM EDT
2.860
+0.080 (2.88%)
After-hours: Jul 10, 2026, 7:22 PM EDT
Adial Pharmaceuticals Earnings Call Transcripts
Fiscal Year 2026
-
The acquisition brings a novel, colon-targeted therapy for ulcerative colitis and up to $64M in financing, with Azora equity holders gaining majority ownership. The combined company will focus on advancing AT177 through early clinical milestones.